BIOSPECIFICS TECHNOLOGIES CORP 4
4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Jul 21, 2015
Insider Transaction Report
Form 4
Gitman Paul
Director
Transactions
- Sale
Common Stock, $0.001 par value
2015-07-20$53.00/sh−8,692$460,676→ 51,825 total - Exercise/Conversion
Common Stock, $0.001 par value
2015-07-20$13.60/sh+8,692$118,211→ 60,517 total - Exercise/Conversion
Stock Option (Right to Buy)
2015-07-20−8,692→ 0 totalExercise: $13.60Exp: 2018-06-09→ Common Stock, $0.001 par value (8,692 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2015.
- [F2]All 8,692 shares sold on July 20, 2015 were executed at a price point of $53.00.
- [F3]The option was granted on June 10, 2008 and it was to vest monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested. All shares underlying the option have vested.